A novel glycopyrrolate metered dose inhaler formulation demonstrates superior bronchodilator efficacy relative to placebo and comparable efficacy and safety to Spiriva® Handihaler® in patients with COPD

Category Primary study
JournalAmerican Journal of Respiratory and Critical Care Medicine
Year 2010
This article has no abstract
Epistemonikos ID: 5e91dafb83d4fef9472890cb5c838bb8f9295f3c
First added on: Feb 05, 2025